Publication

Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet

Downloadable Content

Persistent URL
Last modified
  • 02/25/2025
Type of Material
Authors
    Sara M. Lammert, Massachusetts General HospitalSowmya R. Rao, Boston University Medical CenterEmily S. Jentes, Centers for Disease Control and PreventionJessica Fairley, Emory UniversityStefanie Erskine, Centers for Disease Control and PreventionAllison T. Walker, Centers for Disease Control and PreventionStefan H. Hagmann, Bronx-Lebanon Hospital CenterMark J. Sotir, Centers for Disease Control and PreventionEdward T. Ryan, Harvard Medical SchoolRegina C. LaRocque, Harvard Medical School
Language
  • English
Date
  • 2016-10-30
Publisher
  • Oxford University Press (OUP): Policy B - Oxford Open Option B - CC-BY
Publication Version
Copyright Statement
  • © International Society of Travel Medicine, 2016. Published by Oxford University Press.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1195-1982
Volume
  • 24
Issue
  • 1
Start Page
  • 075
End Page
  • 075
Grant/Funding Information
  • This work was supported by US Centers for Disease Control and Prevention Grants [U19CI000514, U01CK000175].
Abstract
  • Background: International travellers are at risk of travel-related, vaccine-preventable diseases. More data are needed on the proportion of travellers who refuse vaccines during a pre-travel health consultation and their reasons for refusing vaccines. Methods: We analyzed data on travellers seen for a pre-travel health consultation from July 2012 through June 2014 in the Global TravEpiNet (GTEN) consortium. Providers were required to indicate one of three reasons for a traveller refusing a recommended vaccine: (1) cost concerns, (2) safety concerns or (3) not concerned with the illness. We calculated refusal rates among travellers eligible for each vaccine based on CDC recommendations current at the time of travel. We used multivariable logistic regression models to examine the effect of individual variables on the likelihood of accepting all recommended vaccines. Results: Of 24 478 travellers, 23 768 (97%) were eligible for at least one vaccine. Travellers were most frequently eligible for typhoid (N = 20 092), hepatitis A (N = 12 990) and influenza vaccines (N = 10 539). Of 23 768 eligible travellers, 6573 (25%) refused one or more recommended vaccine(s). Of those eligible, more than one-third refused the following vaccines: meningococcal: 2232 (44%) of 5029; rabies: 1155 (44%) of 2650; Japanese encephalitis: 761 (41%) of 1846; and influenza: 3527 (33%) of 10 539. The most common reason for declining vaccines was that the traveller was not concerned about the illness. In multivariable analysis, travellers visiting friends and relatives (VFR) in low or medium human development countries were less likely to accept all recommended vaccines, compared with non-VFR travellers (OR = 0.74 (0.59–0.95)). Conclusions: Travellers who sought pre-travel health care refused recommended vaccines at varying rates. A lack of concern about the associated illness was the most commonly cited reason for all refused vaccines. Our data suggest more effective education about disease risk is needed for international travellers, even those who seek pre-travel advice.
Author Notes
Keywords
Research Categories
  • Health Sciences, Immunology
  • Health Sciences, Public Health

Tools

Relations

In Collection:

Items